Subscribe To
Markets rally as fed, boe bolster rate relief hopes
Share and bond markets extended a global rally on Thursday as non-committal Federal Reserve and Bank of England chiefs had traders ...
November 2, 2023, 11:59 pm
Apple paid subscriptions top 1 billion, doubling in three years
Apple's services notched double-digit revenue growth in the quarter, and management pointed to continued consumer enthusiasm for content, subscription...
November 2, 2023, 8:26 pm
Revolut doubles financial crime head count in bid to police fraud
Revolut, the fintech startup recognized for its innovative banking solutions, has announced the doubling...
October 31, 2023, 5:06 pm
The 3 best ev stocks to buy in november
It is undeniable that the world is shifting to electric vehicles. Major automakers have substantially ramped up their production, with certain compani...
October 31, 2023, 4:26 pm
Bitcoin shows no signs of overheating, despite doubling this year: analysis
Bitcoin has doubled this year. The bullish trend may continue unabated as key indicator shows no signs of overheating, according to IntoTheBlock. Read...
October 31, 2023, 5:44 am
Bitcoin shows no signs of overheating, despite doubling this year
Bitcoin [BTC], the leading cryptocurrency by market value, has doubled this year to over $34,000. Still, the market shows no signs of … Read Full St...
October 30, 2023, 1:47 pm
Mysize expects to nearly double full-year revenue in 2023
MySize Inc (NASDAQ:MYSZ) said it now expects to report revenue for 2023 of $8 million, nearly doubling ...
October 30, 2023, 9:59 am
Nasdaq correction: 2 faang stocks to buy like they're going out of style
Tech stocks have pulled back as interest rates have risen and AI hype has faded. Meta Platforms made an impressive recovery with revenue surging and p...
October 29, 2023, 7:19 am
Can casino stocks win big if economy slows?
If the economy is headed for a slowdown or recession, as many analysts expect, you might instantly think about ...
October 27, 2023, 10:44 am
3 great foreign companies to invest in right now
Unilever is executing well as it looks to turn its business toward growth. Enbridge is doubling down on...
October 26, 2023, 9:03 am
Meta posts 23% growth as ads rebound, with profit more than doubling
The internet company's cost cuts also helped lift its financial performance in the most recent quarter....
October 25, 2023, 4:39 pm
Why exxon and chevron are doubling down on fossil fuel energy with big acquisitions
Exxon and Chevron's recent acquisitions show that despite global decarbonization pushes, the energy transition is likely to be long and slow....
October 25, 2023, 8:00 am
Dutch health tech company philips raises outlook as q3 profit jumps
Dutch health technology company Philips on Monday raised its full-year outlook as it beat analyst expectations with a more than ...
October 23, 2023, 1:11 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am